← Back to patent-cliff list
CAS 1450983-43-3
N-(pyrimidin-2-ylmethyl)formamide
Codes：AVAN-021
Application context (from source-drug indications)
勃起功能障碍阿伐那非
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 阿伐那非Avanafil | Tier C — Watch / trade | 2028 |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(S)-pyrrolidin-2-ylmethanol→4-(bromomethyl)-2-chloro-1-methoxybenzene→4-aminopyrimidin-2(1H)-one→4-((3-chloro-4-methoxybenzyl)amino)pyrimidin-2(1H)-one→(S)-(1-(4-((3-chloro-4-methoxybenzyl)amino)pyrimidin-2-yl)pyrrolidin-2-yl)methanol→N-(pyrimidin-2-ylmethyl)formamide
(S)-pyrrolidin-2-ylmethanol→4-(bromomethyl)-2-chloro-1-methoxybenzene→4-aminopyrimidin-2(1H)-one→4-((3-chloro-4-methoxybenzyl)amino)pyrimidin-2(1H)-one→N-(pyrimidin-2-ylmethyl)formamide→4-((3-chloro-4-methoxybenzyl)amino)-2-oxo-N-(pyrimidin-2-ylmethyl)-1,2-dihydropyrimidine-5-carboxamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.